| Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065) |
|---|
| 05/12/2011 | US20110112026 Factor viii polymer conjugates |
| 05/12/2011 | US20110112025 Factor viii polymer conjugates |
| 05/12/2011 | US20110112024 Factor viii polymer conjugates |
| 05/12/2011 | US20110112023 Von willebrand factor or factor viii and von willebrand factor for the treatment of coagulopathy induced by inhibitors of thrombocytes |
| 05/12/2011 | US20110112016 Compositions and methods for modulating the immune system |
| 05/12/2011 | US20110112014 Supplementation of propane-1,2,3-triol and water in fasting subjects |
| 05/12/2011 | US20110111058 Methods for increasing the stabilization of hypoxia inducible factor-1 alpha |
| 05/12/2011 | US20110111037 Orodispersible mannitol |
| 05/12/2011 | US20110111029 Composition for transdermal delivery of cationic active agents |
| 05/12/2011 | US20110111003 Stable cell binding chimeric peptides |
| 05/12/2011 | US20110110961 Prolyl hydroxylase inhibitors |
| 05/12/2011 | US20110110946 Soluble receptor br43x2 and methods of using |
| 05/12/2011 | US20110110938 Compositions and methods for the treatment of immune related diseases |
| 05/12/2011 | US20110110930 Mitogen-Activated Protein Kinase Kinase Kinase 14 (MAP3K14) Polymorphisms As Indicators of Subject Outcome in Critically Ill Subjects |
| 05/12/2011 | US20110110921 Methods for Treating Bleeding Disorders |
| 05/12/2011 | US20110110915 14189, a novel human kinase and uses thereof |
| 05/12/2011 | US20110110909 Human facilitating cells |
| 05/12/2011 | US20110110901 Methods of long-term culture of eukaryotic cells and uses thereof |
| 05/11/2011 | EP2319928A1 Dimeric thrombopoietin peptide mimetics binding to MP1 receptor and having thrombopoietic activity |
| 05/11/2011 | EP2319870A2 Human antibodies that bind human IL-12 and methods for producing |
| 05/11/2011 | EP2319838A1 Therapeutic Molecules and Methods-1 |
| 05/11/2011 | EP2319835A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group |
| 05/11/2011 | EP2319541A1 Factor VII or VIIA-like conjugates |
| 05/11/2011 | EP2319537A1 Stabilizer for lymph vessel |
| 05/11/2011 | EP2319535A2 Pharmaceutical composition for treatment of diseases caused by IL-6 production |
| 05/11/2011 | EP2319528A2 Methods of increasing platelet and hematopoietic stem cell production |
| 05/11/2011 | EP2319527A2 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 05/11/2011 | EP2319523A1 Serine protease inhibitors |
| 05/11/2011 | EP2318415A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 05/11/2011 | EP1001755B1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them |
| 05/11/2011 | CN201823042U Smokeless medicinal bean blowing moxibustion instrument |
| 05/11/2011 | CN201823037U Double-foot sole massager filled with changeable essential oil bearing spices |
| 05/11/2011 | CN1899614B Preparation for the prophylaxis of restenosis |
| 05/11/2011 | CN1845917B 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1h-benzimidazol-5-carbonyl)-pyridine-2-yl-amino]-propionic acid ethyl ester methane sulphonate and use thereof as a medicament |
| 05/11/2011 | CN102056923A New co-crystal compound of rivaroxaban and malonic acid |
| 05/11/2011 | CN102056922A Macrocyclic urea and sulfamide derivatives as inhibitors of TAFIA |
| 05/11/2011 | CN102056907A Heterocyclic derivative and use thereof |
| 05/11/2011 | CN102056630A Stabilizer for lymph vessel |
| 05/11/2011 | CN102051392A Chlorhematin and preparation method thereof as well as blood-enriching pharmaceutical composition |
| 05/11/2011 | CN102051321A Red jujube health-care liquor and production process thereof |
| 05/11/2011 | CN102050860A Preparation method of 24(R)-ocotillol DQ and pharmacal application thereof |
| 05/11/2011 | CN102050828A Prasugrel salt and preparation method thereof |
| 05/11/2011 | CN102050819A Oxazolidone derivative as well as preparation method and purposes thereof |
| 05/11/2011 | CN102050815A Dabigatran ester derivatives as prodrug |
| 05/11/2011 | CN102050814A Ester derivatives of dabigatran |
| 05/11/2011 | CN102049035A Starch polysaccharide-iron compound preparation |
| 05/11/2011 | CN102049032A Oral liquid capable of strengthening spleen, replenishing qi and nourishing blood and preparation method thereof |
| 05/11/2011 | CN102048984A Blood tonifying tablets and preparation method thereof |
| 05/11/2011 | CN102048981A TCM prescription for treating aplastic anemia |
| 05/11/2011 | CN102048937A Chinese medicinal composition for treating and resisting platelet aggregation |
| 05/11/2011 | CN102048929A Xiaoyukang tablet and preparation method thereof |
| 05/11/2011 | CN102048921A Kang'ai body resistance-strengthening and preparation method thereof |
| 05/11/2011 | CN102048909A Callicarpa nudiflora effective part with hemostatic effect and pharmaceutical preparation thereof |
| 05/11/2011 | CN102048905A Oral liquid for benefiting qi, nourishing blood and beautifying face and preparation process thereof |
| 05/11/2011 | CN102048902A Traditional Chinese medicine preparation and traditional Chinese medicine extract as well as preparation method, application and formulation of traditional Chinese medicine extract |
| 05/11/2011 | CN102048888A Pharmaceutical composition for eliminating thrombus |
| 05/11/2011 | CN102048869A TCM prescription for treating jaundice of newborn |
| 05/11/2011 | CN102048834A Traditional Chinese medicine for treating cirrhosis ascites |
| 05/11/2011 | CN102048796A Rhodiola rosea extract testing method |
| 05/11/2011 | CN102048761A Preparation method of enteric coated tablet with leech as raw material |
| 05/11/2011 | CN102048753A Preparation method and applications of Tibetan medical decoction iron powder |
| 05/11/2011 | CN102048726A Application of nobiletin |
| 05/11/2011 | CN102048687A Preparation method for alprostadil injection |
| 05/11/2011 | CN102048685A Pefloxacin mesylate injection and preparation method and application thereof |
| 05/11/2011 | CN102048172A Novel squid ink melanin chelate iron preparation method and application of method |
| 05/11/2011 | CN102048160A Use of ampelopsin in preparation of healthcare food and medicaments for protecting vascular endothelial cells |
| 05/11/2011 | CN101664512B Method for preparing traditional Chinese medicine preparation containing herba sarcandrae extracts |
| 05/11/2011 | CN101664087B Health-care liver benefiting tea |
| 05/11/2011 | CN101632819B Preparation for resisting suppression of bone marrow after lung cancer chemotherapy |
| 05/11/2011 | CN101612273B Medicine composition used for treating hemiplegia and cerebral thrombus |
| 05/11/2011 | CN101537191B Recomposed tPA gene-chitosan nanoparticle complex and preparation method thereof |
| 05/11/2011 | CN101508685B Improved preparation method for cinepazide maleate |
| 05/11/2011 | CN101502539B Method for preparing ginkgo leaf extract cyclodextrin inclusion compound and preparation |
| 05/11/2011 | CN101492457B Method of preparing hydronol |
| 05/11/2011 | CN101463038B Production method of (-)-(R)- clopidogrel (-)-(R)-camphorsulfonate racemisation |
| 05/11/2011 | CN101439025B Silymarin high-efficient long-acting preparation and production method thereof |
| 05/11/2011 | CN101428131B Medicament for treating tympany |
| 05/11/2011 | CN101348786B Human beta-globin gene and recombinant adenovirus related virus vector thereof |
| 05/11/2011 | CN101327202B Vitamin K1 lyophilized powder for injection and preparation method |
| 05/11/2011 | CN101306196B Biodegradable nano-particles bonded with hemoglobin and production method thereof |
| 05/11/2011 | CN101254302B Treatment of autoimmune diseases with antagonists which bind to b cell surface markers |
| 05/11/2011 | CN101152243B Traditional Chinese medicine for treating apoplexy and technique of preparing the same |
| 05/10/2011 | US7939670 Nociceptin analogs |
| 05/10/2011 | US7939625 Somatostatin analogues |
| 05/10/2011 | CA2485535C Modified release pharmaceutical formulation |
| 05/10/2011 | CA2463102C Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors |
| 05/10/2011 | CA2436935C Serine protease inhibitors |
| 05/10/2011 | CA2419633C Substituted imidazoles as tafia inhibitors |
| 05/10/2011 | CA2419385C Saratin for inhibiting platelet adhesion to collagen |
| 05/10/2011 | CA2418815C Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 05/10/2011 | CA2416293C Somatostatin analogues |
| 05/05/2011 | WO2011052950A2 Pharmaceutical composition comprising indole compound |
| 05/05/2011 | WO2011052500A1 Wax stable formulation |
| 05/05/2011 | WO2011052499A1 Pharmaceutical composition having improved storage stability |
| 05/05/2011 | WO2011050590A1 Polymorph of 3-(substituteddihydroisoindolinone-2-yl)-2,6-dioxopiperidine, and pharmaceutical compositions thereof |
| 05/05/2011 | US20110107443 Novel protein transduction domains derived from secretory leukocyte protease inhibitor |
| 05/05/2011 | US20110105616 Novel lysine salts of 4-((phenoxyalkyl)thio)-phenoxyacetic acid derivatives |
| 05/05/2011 | US20110105557 Farnesyl protein transferase inhibitor combinations with antiestrogen agents |
| 05/05/2011 | US20110105533 Heterocyclic Sulfonamides, Uses and Pharmaceutical Compositions Thereof |
| 05/05/2011 | US20110105490 2,3-dihydro-1h-isoindol-1-imine derivatives useful as thrombin par-1 receptor antagonist |